Cox Troy
- SEC CIK
- 0001696923
In the past year, 1 open-market purchase filing worth $148.7K and no sales.
Current role at each company
- MPLT MapLight Therapeutics, Inc.Directoras of Jul 28, 2026
- LAB Standard Biotools Inc.Directoras of Jun 23, 2026
- SOPH SOPHiA GENETICS SADirectoras of Jun 22, 2026
- ZYME Zymeworks Inc.Directoras of Dec 12, 2024
- SLGC SomaLogic, Inc.Directoras of Jan 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $148.7K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$148.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cox Troy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MPLT MapLight Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 (view filing)9:14 PM ET | Jul 28 | Same day | Cox TroyDirector | PPurchaseVoting Common Stock | +15.6K | $9.52 | +$148.7K | New position15.6K after |